DE69911441D1 - Verwendung von carnitinen und resveratrol zur herstellung einer zusammensetzung zur verhinderung oder behandlung von zerebralenerkrankungen verursacht durch alterung und verwendung neurotoxischer mittel - Google Patents
Verwendung von carnitinen und resveratrol zur herstellung einer zusammensetzung zur verhinderung oder behandlung von zerebralenerkrankungen verursacht durch alterung und verwendung neurotoxischer mittelInfo
- Publication number
- DE69911441D1 DE69911441D1 DE69911441T DE69911441T DE69911441D1 DE 69911441 D1 DE69911441 D1 DE 69911441D1 DE 69911441 T DE69911441 T DE 69911441T DE 69911441 T DE69911441 T DE 69911441T DE 69911441 D1 DE69911441 D1 DE 69911441D1
- Authority
- DE
- Germany
- Prior art keywords
- carnitines
- resveratrol
- aging
- preventing
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 title 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 title 1
- 230000032683 aging Effects 0.000 title 1
- 230000002490 cerebral effect Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000002581 neurotoxin Substances 0.000 title 1
- 229940016667 resveratrol Drugs 0.000 title 1
- 235000021283 resveratrol Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Botany (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM980636 | 1998-10-09 | ||
IT1998RM000636A IT1302365B1 (it) | 1998-10-09 | 1998-10-09 | Uso di carnitine e resveratrolo per produrre una composizione per laprevenzione o il trattamento terapeutico di alterazioni cerebrali |
PCT/IT1999/000311 WO2000021526A1 (en) | 1998-10-09 | 1999-10-06 | Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69911441D1 true DE69911441D1 (de) | 2003-10-23 |
DE69911441T2 DE69911441T2 (de) | 2004-07-01 |
Family
ID=11406160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69911441T Expired - Lifetime DE69911441T2 (de) | 1998-10-09 | 1999-10-06 | Verwendung von carnitinen und resveratrol zur herstellung einer zusammensetzung zur verhinderung oder behandlung von zerebralenerkrankungen verursacht durch alterung und verwendung neurotoxischer mittel |
Country Status (27)
Country | Link |
---|---|
US (1) | US6515020B1 (de) |
EP (1) | EP1117394B1 (de) |
JP (1) | JP4166951B2 (de) |
KR (1) | KR20010079981A (de) |
CN (1) | CN1323205A (de) |
AR (1) | AR020762A1 (de) |
AT (1) | ATE249823T1 (de) |
AU (1) | AU767492B2 (de) |
BR (1) | BR9915918A (de) |
CA (1) | CA2344893C (de) |
CZ (1) | CZ2001920A3 (de) |
DE (1) | DE69911441T2 (de) |
DK (1) | DK1117394T3 (de) |
EE (1) | EE200100205A (de) |
ES (1) | ES2207287T3 (de) |
HK (1) | HK1040935A1 (de) |
HU (1) | HU229364B1 (de) |
IL (1) | IL142046A0 (de) |
IS (1) | IS5896A (de) |
IT (1) | IT1302365B1 (de) |
NO (1) | NO20011693D0 (de) |
PL (1) | PL197342B1 (de) |
PT (1) | PT1117394E (de) |
SK (1) | SK3782001A3 (de) |
TN (1) | TNSN99186A1 (de) |
TR (1) | TR200100947T2 (de) |
WO (1) | WO2000021526A1 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002047193A (ja) * | 2000-07-31 | 2002-02-12 | Sunstar Inc | アレルギー性皮膚炎予防または治療用組成物 |
WO2002038142A2 (en) * | 2000-11-08 | 2002-05-16 | Massachusetts Institute Of Technology | Serotonergic compositions and methods for treatment of mild cognitive impairment |
BRPI0106382B1 (pt) * | 2001-03-13 | 2017-07-11 | Universidade Do Estado Do Rio De Janeiro - Uerj | Process for obtaining decocts from vitis labrusca and vitis vinifera casts, process for obtaining the hydro-alcoholic extract, process for obtaining the hydro-alcoholic extract-ethyl acetate and pharmaceutical compositions |
EP1284133B1 (de) * | 2001-08-18 | 2006-10-11 | Cognis IP Management GmbH | Wirkstoffmischungen |
US20070218151A1 (en) * | 2002-03-12 | 2007-09-20 | Universidade Do Estado Do Rio De Janeiro | Process for obtention of decoctions of Vitis labrusca and Vitis vinifera skins |
US7977049B2 (en) * | 2002-08-09 | 2011-07-12 | President And Fellows Of Harvard College | Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
KR100574392B1 (ko) * | 2003-02-07 | 2006-05-02 | 재단법인서울대학교산학협력재단 | 신경보호활성을 갖는 신규 페닐환 유도체 및 이를함유하는 약학 조성물 |
CA2529510A1 (en) * | 2003-07-01 | 2005-01-13 | President And Fellows Of Harvard College | Compositions for manipulating the lifespan and stress response of cells and organisms |
US20060025337A1 (en) * | 2003-07-01 | 2006-02-02 | President And Fellows Of Harvard College | Sirtuin related therapeutics and diagnostics for neurodegenerative diseases |
KR100543056B1 (ko) * | 2003-11-07 | 2006-01-20 | (주)네추럴에프앤피 | 신경세포 보호 활성이 있는 포도씨 추출물을 포함하는뇌질환 예방 및 치료용 조성물 |
EP1708689A2 (de) | 2003-12-29 | 2006-10-11 | The President and Fellows of Harvard College | Zusammensetzungen zur behandlung oder verhinderung von adipositas und insulin-resistenten erkrankungen |
US8017634B2 (en) | 2003-12-29 | 2011-09-13 | President And Fellows Of Harvard College | Compositions for treating obesity and insulin resistance disorders |
ES2245609B1 (es) * | 2004-06-18 | 2007-08-16 | Universidad De Barcelona | Nuevo agente terapeutico para el tratamiento de la infertilidad y/o subfertilidad masculina en mamiferos. |
US20060014705A1 (en) * | 2004-06-30 | 2006-01-19 | Howitz Konrad T | Compositions and methods for selectively activating human sirtuins |
US20060121137A1 (en) * | 2004-12-07 | 2006-06-08 | Hartle Diane K | Muscadine grape pomace in the treatment of intestinal inflammation |
JP2008527002A (ja) * | 2005-01-13 | 2008-07-24 | サートリス ファーマシューティカルズ, インコーポレイテッド | 神経変性障害および血液凝固障害を予防および処置するための新規組成物 |
WO2006138418A2 (en) * | 2005-06-14 | 2006-12-28 | President And Fellows Of Harvard College | Improvement of cognitive performance with sirtuin activators |
CN101296693B (zh) * | 2005-10-26 | 2012-07-04 | 花王株式会社 | 持久力提高剂 |
FR2898493B1 (fr) * | 2006-03-16 | 2008-08-08 | Af Consulting | Compositions cosmetiques, pharmaceutiques, alimentaires et veterinaires dont l'action d'activation de genes de type sirtuin permet de retarder le vieillissement des mammiferes et ses effets nefastes |
US20120016037A1 (en) * | 2006-07-24 | 2012-01-19 | Frank Toppo | Method for prevention and treatment of Alzheimers |
WO2008091710A2 (en) * | 2007-01-26 | 2008-07-31 | Washington University | Methods and compositions for treating neuropathies |
AT506014A1 (de) * | 2007-10-24 | 2009-05-15 | Karl Mag Dr Zehethofer | Functional drink |
PT2582368T (pt) * | 2010-06-16 | 2018-06-04 | Alfasigma Spa | Acetil-carnitina, para utilização num método para o aumento da neurogénese em tecido neuronal |
KR101327936B1 (ko) * | 2011-07-06 | 2013-11-13 | 한국식품연구원 | 옥시레스베라트롤 이민 유도체를 유효성분으로 함유하는 뇌신경보호 효과를 가지는 조성물 |
CN102919943A (zh) * | 2012-10-26 | 2013-02-13 | 郑全辉 | 保健饮品-葡藤素 |
CN103877170B (zh) * | 2012-12-19 | 2015-11-04 | 中国医学科学院药用植物研究所 | 一种虎杖的乙酸乙酯提取物及其制备方法和应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4346107A (en) * | 1979-02-12 | 1982-08-24 | Claudio Cavazza | Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism |
IT1276225B1 (it) | 1995-10-17 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per |
IT1283967B1 (it) * | 1996-03-29 | 1998-05-07 | Sigma Tau Ind Farmaceuti | Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi |
WO1998033494A1 (en) | 1997-02-04 | 1998-08-06 | Kosbab John V | Compositions and methods for prevention and treatment of vascular degenerative diseases |
IT1291113B1 (it) * | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizione nutritiva terapeutica per soggetti affetti da diabete mellito |
CH692837A5 (it) * | 1997-07-02 | 2002-11-29 | Lisapharma Spa | Composizione farmaceutica per uso alimentare, dietetico o medicinale adatta a migliorare l'assorbimento orale dei polifenoli e particolarmente del resveratrolo presenti nell'uva e nei suoi p |
US5904924A (en) | 1997-11-04 | 1999-05-18 | Oncologics, Inc. | Green nutritional powder composition |
AU4084599A (en) * | 1998-05-18 | 1999-12-06 | Oklahoma Medical Research Foundation | Resveratrol inhibition of myeloperoxidase |
-
1998
- 1998-10-09 IT IT1998RM000636A patent/IT1302365B1/it active IP Right Grant
-
1999
- 1999-10-05 TN TNTNSN99186A patent/TNSN99186A1/fr unknown
- 1999-10-06 ES ES99947853T patent/ES2207287T3/es not_active Expired - Lifetime
- 1999-10-06 EP EP99947853A patent/EP1117394B1/de not_active Expired - Lifetime
- 1999-10-06 BR BR9915918-0A patent/BR9915918A/pt not_active Application Discontinuation
- 1999-10-06 EE EEP200100205A patent/EE200100205A/xx unknown
- 1999-10-06 US US09/806,454 patent/US6515020B1/en not_active Expired - Fee Related
- 1999-10-06 CA CA002344893A patent/CA2344893C/en not_active Expired - Fee Related
- 1999-10-06 DE DE69911441T patent/DE69911441T2/de not_active Expired - Lifetime
- 1999-10-06 CZ CZ2001920A patent/CZ2001920A3/cs unknown
- 1999-10-06 PL PL347209A patent/PL197342B1/pl not_active IP Right Cessation
- 1999-10-06 DK DK99947853T patent/DK1117394T3/da active
- 1999-10-06 AT AT99947853T patent/ATE249823T1/de active
- 1999-10-06 SK SK378-2001A patent/SK3782001A3/sk unknown
- 1999-10-06 PT PT99947853T patent/PT1117394E/pt unknown
- 1999-10-06 KR KR1020017004267A patent/KR20010079981A/ko not_active Application Discontinuation
- 1999-10-06 WO PCT/IT1999/000311 patent/WO2000021526A1/en not_active Application Discontinuation
- 1999-10-06 IL IL14204699A patent/IL142046A0/xx unknown
- 1999-10-06 CN CN99811952A patent/CN1323205A/zh active Pending
- 1999-10-06 AU AU61213/99A patent/AU767492B2/en not_active Ceased
- 1999-10-06 JP JP2000575502A patent/JP4166951B2/ja not_active Expired - Fee Related
- 1999-10-06 HU HU0104021A patent/HU229364B1/hu unknown
- 1999-10-06 TR TR2001/00947T patent/TR200100947T2/xx unknown
- 1999-10-08 AR ARP990105115A patent/AR020762A1/es unknown
-
2001
- 2001-03-16 IS IS5896A patent/IS5896A/is unknown
- 2001-04-04 NO NO20011693A patent/NO20011693D0/no not_active Application Discontinuation
-
2002
- 2002-04-17 HK HK02102885.2A patent/HK1040935A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69911441D1 (de) | Verwendung von carnitinen und resveratrol zur herstellung einer zusammensetzung zur verhinderung oder behandlung von zerebralenerkrankungen verursacht durch alterung und verwendung neurotoxischer mittel | |
DE60021266D1 (de) | Verwendungen von zusammensetzungen zur behandlung oder vermeidung von schlafstörungen mit sehr niedrigdosierten cyclobenzaprine | |
DE69941566D1 (de) | N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie | |
DE69913975D1 (de) | Verfahren und vorrichtung für die herstellung von deodorant oder schweisshemmender zusammensetzung | |
DE69822919D1 (de) | Spezifische Antikörper zur Verwendung in der Herstellung pharmazeutischer Zusammensetzungen nützlich für die Vorbeugung oder Behandlung von Gastritis, Magen- und Zwölffingerdarmgeschwüren | |
ATE331522T1 (de) | Zusammensetzung zur behandlung von atemwegs- und hauterkrankungen mit mindestens einem leukotrienantagonist und mindestens einem antihistaminikum | |
BR9507010A (pt) | Processos para aumentar o nível de HBF em um indivíduo e para tratar prevenir ou melhorar b-globina ou outros distúrbios relacionados com HBF | |
DE69938390D1 (de) | Verwendung einer zusammensetzung welche formoterol und budesonide enthält, zur verhinderung oder behandlung eines akuten astmazustandes | |
DE69435330D1 (de) | Verwendung von Botulinumtoxin Typ B zur Herstellung eines Medikaments zur Behandlung von Muskelkrämpfen | |
ATE282591T1 (de) | Thioharnstoffverbindungen, zusammensetzungen sowie verfahren zur behandlung oder verhütung von entzündlichen erkrankungen und atherosklerose | |
DE69716251D1 (de) | Verwendung von oktoxyglyzerin in einer kosmetische und/oder dermatologische zusammensetzung zur behandlung von seborrhea und akne | |
DE59601624D1 (de) | Verwendung von 2-amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzen zur prophylaxe und behandlung der folgen der akuten und chronischen zerebralen minderdurchblutung sowie neurodegenerativer erkrankungen | |
ATE278400T1 (de) | Zusammensetzungen für die verwendung bei der behandlung und prävention von hyperurikämie | |
DE69512288T2 (de) | Verfahren zur Herstellung von Hexafluorpropan und Perfluorpropan | |
ATE220560T1 (de) | Eisen-dextran verbindung zur verwendung als komponente in einer therapeutischen zusammensetzung zur behandlung oder prophylaxe von eisenmangel, sowie verfahren zur herstellung der eisen-dextran verbindung und ihre anwendung zur herstellung einer parenteral anwendbaren therapeutischen zubereitung. | |
DE69702630T2 (de) | Verfahren und Katalysator zur Herstellung von Distickstoffmonoxid | |
DE59504187D1 (de) | Verfahren zur Herstellung von ultrareinem Bisphenol-A und dessen Verwendung | |
DE69810735T2 (de) | Zusammensetzung für die Behandlung von Wasser und deren Verfahren zur Herstellung | |
DE59500700D1 (de) | Verfahren und Mittel zur Herstellung von purpurfarbenen Dekoren | |
ATE246518T1 (de) | Egr-1 zur herstellung eines medikamentes zur behandlung von wunden | |
DE69900339D1 (de) | Mittel und Verfahren zur Behandlung von Kunstfasern | |
DE59705697D1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis | |
DE69128406T2 (de) | Lateraler MOSFET und Verfahren zur Herstellung | |
DE69930725D1 (de) | Verfahren und kits zur behandlung von vulvovaginalen candidosen mit mikonazolnitrat | |
DE59600371D1 (de) | Verfahren zur Herstellung von Polybenzoxazol-Vorstufen und entsprechender Resistlösungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |